Načítá se...
The emergence of NS5B resistance associated substitution S282T after sofosbuvir‐based treatment
S282T in NS5B is the primary amino acid substitution associated with resistance to sofosbuvir (SOF) but has rarely been detected in patients treated with a SOF‐based regimen. Here, the emergence and fitness of the S282T substitution in virologic failure patients administered SOF‐based regimens acros...
Uloženo v:
| Vydáno v: | Hepatol Commun |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5678900/ https://ncbi.nlm.nih.gov/pubmed/29404477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1060 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|